MAP PHARMACEUTICALS, INC. Patent Applications Rejected
29 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2019-12-05: Application 16704867; Invention METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO ENABLE RAPID RELIEF OF MIGRAINE WHILE MINIMIZING SIDE EFFECT PROFILE; Applicant MAP Pharmaceuticals, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
- 2019-03-01: Application 16290620; Invention ENHANCED EDUCTOR DESIGN; Applicant MAP Pharmaceuticals, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
- 2018-09-11: Application 16127734; Invention METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO ENABLE RAPID RELIEF OF MIGRAINE WHILE MINIMIZING SIDE EFFECT PROFILE; Applicant MAP Pharmaceuticals, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
- 2017-05-03: Application 15585925; Invention 8'-HYDROXY-DIHYDROERGOTAMINE COMPOUNDS AND COMPOSITIONS; Applicant MAP Pharmaceuticals, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2019-12-05 | 16704867 | METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO ENABLE RAPID RELIEF OF MIGRAINE WHILE MINIMIZING SIDE EFFECT PROFILE | MAP Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20200352939A1 | Robert O. Cook Stephen B. Shrewsbury Nabih N. Ramadan Thomas A. Armer | United States United States United States United States | ANDERSON, JAMES D |
| 2019-03-01 | 16290620 | ENHANCED EDUCTOR DESIGN | MAP Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20200030555A1 | Benjamin Stedman Prashant Kakade Darrell Woehler John Leonard | United States United States United States United States | SIPPEL, RACHEL T |
| 2018-09-11 | 16127734 | METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO ENABLE RAPID RELIEF OF MIGRAINE WHILE MINIMIZING SIDE EFFECT PROFILE | MAP Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20190247393A1 | Robert O. Cook Stephen B. Shrewsbury Nabih N. Ramadan Thomas A. Armer | United States United States United States United States | ANDERSON, JAMES D |
| 2017-05-03 | 15585925 | 8'-HYDROXY-DIHYDROERGOTAMINE COMPOUNDS AND COMPOSITIONS | MAP Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20170231976A1 | Thomas Armer Shashidhar Kori Libo Wu | United States United States United States | HARTSFIELD, KATHRIEN ANN |
| 2017-03-23 | 15467593 | HEADACHE PRE-EMPTION BY DIHYDROERGOTAMINE TREATMENT DURING HEADACHE PRECURSOR EVENTS | MAP Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20170189397A1 | Robert Owen Cook Paul L. Durham Shashi Kori Thomas A. Armer | United States United States United States United States | HOWELL, THEODORE R |
| 2016-11-15 | 15351632 | ENHANCED EDUCTOR DESIGN | MAP Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20170056609A1 | Benjamin Stedman Prashant Kakade Darrell Woehler John Leonard | United States United States United States United States | SIPPEL, RACHEL T |
| 2016-09-22 | 15272597 | DOSE COUNTER WITH LOCKOUT MECHANISM | MAP Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20170007786A1 | Alfred Sugianto | United States | YAO, SAMCHUAN CUA |
| 2016-05-23 | 15161389 | 8'-HYDROXY-DIHYDROERGOTAMINE COMPOUNDS AND COMPOSITIONS | MAP Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20160263101A1 | Donald J. Kellerman Thomas Armer Jian Zhang | United States United States United States | HARTSFIELD, KATHRIEN ANN |
| 2015-11-17 | 14943347 | METHODS AND APPARATUS FOR DELIVERING AEROSOLIZED MEDICATION | MAP Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20160067429A1 | Prashant Kakade | United States | VASAT, PETER S |
| 2015-06-02 | 14728203 | AEROSOL COMPOSITION FOR ADMINISTERING DRUGS | MAP Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20150265531A1 | Libo Wu Wiwik Watanabe | United States United States | SOROUSH, LAYLA |
| 2015-04-29 | 14699797 | ADMINISTRATION OF DIHYDROERGOTAMINE MESYLATE PARTICLES USING A METERED DOSE INHALER | MAP Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20150238412A1 | Donald J. Kellerman Shashidhar H. Kori Scott W. Borland Thomas A. Armer | United States United States United States United States | PRYOR, ALTON NATHANIEL |
| 2015-04-29 | 14699675 | 8'-HYDROXY-DIHYDROERGOTAMINE COMPOUNDS AND COMPOSITIONS | MAP Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20150306096A1 | Thomas Armer Shashidhar Kori Libo Wu | United States United States United States | HARTSFIELD, KATHRIEN ANN |
| 2015-04-28 | 14697906 | NOVEL ERGOLINE DERIVATIVES AND USES THEREOF | MAP Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20150238487A1 | Thomas Armer Shashidhar Kori Libo Wu | United States United States United States | HARTSFIELD, KATHRIEN ANN |
| 2015-03-27 | 14670953 | Novel Cabergoline Derivatives | MAP Pharmaceuticals, Inc. | Abandoned -- Failure to Pay Issue Fee | US20150202198A1 | Jian Zhang Thomas A. Armer | United States United States | KIM, JENNIFER M |
| 2015-01-09 | 14593792 | FLUOROERGOLINE DERIVATIVES AND USES THEREOF | MAP PHARMACEUTICALS, INC. | Abandoned -- Failure to Respond to an Office Action | US20150133456A1 | Thomas Armer Shashidhar Kori Libo Wu | United States United States United States | WILLIS, DOUGLAS M |
| 2014-10-22 | 14520522 | NOVEL METHYSERGIDE DERIVATIVES | MAP Pharmaceuticals, Inc. | Abandoned -- Failure to Pay Issue Fee | US20150038525A1 | Libo WU Jian ZHANG | United States United States | AULAKH, CHARANJIT |
| 2014-10-14 | 14514322 | METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO ENABLE RAPID RELIEF OF MIGRAINE WHILE MINIMIZING SIDE EFFECT PROFILE | MAP Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20150057287A1 | Robert O. Cook Stephen B. Shrewsbury Nabih N. Ramadan Thomas A. Armer | United States United States United States United States | ANDERSON, JAMES D |
| 2014-09-30 | 14503027 | Method of Using Dihydroergotamine for Pre-emptive Treatment of Migraine | MAP Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20150023888A1 | ROBERT O. COOK PAUL L. DURHAM | United States United States | CHERNYSHEV, OLGA N |
| 2014-07-08 | 14326197 | METHODS FOR ADMINISTERING CORTICOSTEROID FORMULATIONS | MAP Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20140323451A1 | STEPHEN B. SHREWSBURY PAUL S. USTER ANDREW P. BOSCO THOMAS A. ARMER | United States United States United States United States | SZNAIDMAN, MARCOS L |
| 2014-06-18 | 14308007 | SUSTAINED-RELEASE FORMULATION OF ROTIGOTINE | MAP Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20140377365A1 | Libo WU Wiwik WATANABE | United States United States | SOROUSH, ALI |
| 2014-06-18 | 14307998 | PULMONARY ADMINISTRATION OF ROTIGOTINE | MAP Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20140377189A1 | Libo WU Wiwik WATANABE | United States United States | BOSWELL, AMANDA E |
| 2014-03-10 | 14202875 | SUBSTITUTED INDOLO[4,3-FG]QUINOLINES FOR TREATING MIGRAINE | MAP Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20140194435A1 | Robert O. COOK Thomas A. ARMER Sergey Alexandrovich KOSAREV Dejian XIE Jian ZHANG | United States United States Singapore China United States | WILLIS, DOUGLAS M |
| 2014-03-10 | 14202744 | SUBSTITUTED INDOLO[4,3-FG]QUINOLINES FOR TREATING MIGRAINE | MAP Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20140194434A1 | Robert O. Cook THOMAS A. ARMER Sergey Alexandrovich KOSAREV Dejian Xie Jian Zhang | United States United States Singapore China United States | WILLIS, DOUGLAS M |
| 2013-12-19 | 14134127 | NOVEL ERGOLINE DERIVATIVES AND USES THEREOF | MAP PHARMACEUTICALS, INC. | Abandoned -- Failure to Respond to an Office Action | US20140179707A1 | Thomas Armer Shashidhar Kori Libo Wu | United States United States United States | HARTSFIELD, KATHRIEN ANN |
| 2013-12-19 | 14134120 | FLUOROERGOLINE DERIVATIVES AND USES THEREOF | MAP PHARMACEUTICALS, INC. | Abandoned -- Failure to Respond to an Office Action | US20140179706A1 | Thomas Armer Shashidhar Kori Libo Wu | United States United States United States | WILLIS, DOUGLAS M |
| 2013-12-19 | 14134105 | 8'-HYDROXY-DIHYDROERGOTAMINE COMPOUNDS AND COMPOSITIONS | MAP PHARMACEUTICALS, INC. | Abandoned -- Failure to Respond to an Office Action | US20140179705A1 | Thomas Armer Shashidhar Kori Libo Wu | United States United States United States | HARTSFIELD, KATHRIEN ANN |
| 2013-12-04 | 14097089 | Synthesis of Small Particles | MAP Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20140086994A1 | Neil Russell Foster Hubert Leonardus Regtop Fariba Dehghani | Australia Australia Australia | THEISEN, MARY LYNN F |
| 2013-10-02 | 14044456 | CORTICOSTEROID PARTICLES AND METHOD OF PRODUCTION | MAP PHARMACEUTICALS, INC. | Abandoned -- Failure to Pay Issue Fee | US20140120165A1 | Libo Wu Wiwik Watanabe Jian Zhang | United States United States United States | COHEN, MICHAEL P |
| 2012-12-20 | 13721444 | Excipient-free Aerosol Formulation | MAP PHARMACEUTICALS, INC. | Abandoned -- Failure to Respond to an Office Action | US20130156823A1 | Libo WU Wiwik Watanabe | United States United States | CAO, PING |